iNKT cells: Clinical Trials

2 trials of iNKT cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Completed 1

Follow iNKT cells: new trials by email Literature Review of iNKT cells trials Research Report on iNKT cells

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular Carcinoma
GKL-006 Injection, Transarterial chemoembolization (TACE) - Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Cancer
Phase 1Active not recruitingBeijing Gene Key Life Technology Co., Ltd62025-04-032026-07-20
Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC
iNKT cells, IL-2, Tegafur - Hepatocellular Carcinoma
Phase 1CompletedBeijing YouAn Hospital102017-04-012024-09-19

Conditions studied

Carcinoma, Hepatocellular (2)

Sponsors

Beijing Gene Key Life Technology Co., Ltd (1)  ·  Beijing YouAn Hospital (1)

Countries

China (2)

Top investigators

Jun Lu, Director (1)